Facilitated By

San Antonio Medical Foundation

Target Deliver of Epigallocatechin Gallate by Hemo

59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)

The 59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC) provides support for research conducted by investigators and their collaborators addressing the unique scientific needs of the Air Force, the Department of Defense and the Nation.

Principal Investigator(s)
Dr. Jack Hutcheson
Research Start Date

Traumatic hemorrhage remains the leading cause of combat related preventable deaths due to lack of necessary innovation to stanch non-compressible blood loss in the field, where soldiers are required to rely on limited resources for extend periods of time until evacuation can take place. Combat casualty care options are limited to compact, portable, easily administered therapies. The mounting rise in infectious complication after combat casualty wounds also presents an immediate health risk to after-care of military personnel and impacts the healing process after injury. Infectious complications in combat wounds result in extensive debridement in amputations resulting in further loss in function of limbs. A novel treatment alternative that would stanch hemorrhage and preemptively combat a broad spectrum of pathogens would be superior to what is currently available in both civilian and military medicine.

Collaborative Project
Basic Research
The views expressed are those of the authors and do not reflect the official views or policy of the Department of Defense or its Components. Where applicable, the voluntary fully informed consent of the subjects used in this research was obtained as required by 32 CFR 219 and DODI 3216.02_AFI 40-402